Zyranta
Indications
- Cerebrovascular disease
- Head trauma of varying degrees
- Cognitive disorders of diverse etiology
- Glaucoma
- Ambliopia
- Parkinson’s disease
Established in 2009, ABG has built up a solid foundation in pharmaceutical production technologies. We have overlaid this strength with cutting-edge technologies that we have introduced and consolidated, to maximize effect in pinpointing and utilizing drugs by creating a rapid production system
The ABG Group has introduced multidimensional analysis to select the optimal drugs for development technologies such as these have served as ABG backbone in launching highly competitive clinical drugs and basic research studies and in out-licensing new drugs for the pharmaceutical seeds.